Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily
(QD), taken with established lipid-lowering therapy in subjects with type 2 diabetes
mellitus.